ReviewCurrent oncology (Toronto, Ont.)2026

Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review.

Khashayar Yazdanpanah Ardakani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.